Fundz

Marinus Pharmaceuticals, Inc. reported raising $1.23 Million in an initial SEC Form D filing, from an offering of $1.23 Million

PRIVATEApr 04, 2022

Amount Raised

$1.23 Million

$1.23 Million sold, per SEC Form D (first sale Apr 4, 2022)

Round Type

Seed

RadnorHealthcare

Quick answer

MARINUS PHARMACEUTICALS, INC. raised $1.23 Million in a Seed round, dated April 4, 2022. MARINUS PHARMACEUTICALS, INC. is based in Radnor, Pennsylvania, United States.

How much did MARINUS PHARMACEUTICALS, INC. raise?
MARINUS PHARMACEUTICALS, INC. raised $1.23 Million in a Seed round on April 4, 2022.
What does MARINUS PHARMACEUTICALS, INC. do?
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected..
Where is MARINUS PHARMACEUTICALS, INC. based and how big is it?
MARINUS PHARMACEUTICALS, INC. is based in Radnor, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as MARINUS PHARMACEUTICALS, INC. that raised within 45 days of this round, from Fundz verified event records.

  • Nuo Therapeutics raised $408K (Seed) on May 19, 2022.
  • Zomedica raised an undisclosed amount (Corporate Round) on May 19, 2022.
  • Gilgamesh Pharmaceuticals raised $14M on May 19, 2022.
  • Resilient Lifescience, Inc. raised $75K (Pre-Seed) on May 18, 2022.
  • Aruene Corp raised $2.9M (Seed) on May 18, 2022.
  • Greater Good Healthcare raised $10M (Funding Round) on May 18, 2022.

Who to call at MARINUS PHARMACEUTICALS, INC., and when

A new round usually means MARINUS PHARMACEUTICALS, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MARINUS PHARMACEUTICALS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MARINUS PHARMACEUTICALS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MARINUS PHARMACEUTICALS, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MARINUS PHARMACEUTICALS, INC.

Location

5 Radnor Corporate Center, Suite 500

Radnor, Pennsylvania, United States

About

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MARINUS PHARMACEUTICALS, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for MARINUS PHARMACEUTICALS, INC.'s next move

See what Strategic adds

MARINUS PHARMACEUTICALS, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.